Qeadan, F., McCunn, A., & Tingey, B. (2025). The association between glucose‐dependent insulinotropic polypeptide and/or glucagon‐like peptide‐1 receptor agonist prescriptions and substance‐related outcomes in patients with opioid and alcohol use disorders: A real‐world data analysis. Addiction, 120(2), 236-251.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita Chicago Style (17a ed.)
Qeadan, Fares, Ashlie McCunn, y Benjamin Tingey. "The Association Between Glucose‐dependent Insulinotropic Polypeptide And/or Glucagon‐like Peptide‐1 Receptor Agonist Prescriptions and Substance‐related Outcomes in Patients with Opioid and Alcohol Use Disorders: A Real‐world Data Analysis."
Addiction 120, no. 2 (2025): 236-251.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita MLA (9a ed.)
Qeadan, Fares, et al. "The Association Between Glucose‐dependent Insulinotropic Polypeptide And/or Glucagon‐like Peptide‐1 Receptor Agonist Prescriptions and Substance‐related Outcomes in Patients with Opioid and Alcohol Use Disorders: A Real‐world Data Analysis."
Addiction, vol. 120, no. 2, 2025, pp. 236-251.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Precaución: Estas citas no son 100% exactas.